Jason Graham Vaughn

US Patent:

20080020032, Jan 24, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781088

Inventors:

Michael Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Jason Vaughn - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 31/4355
A61K 9/48

US Classification:

424452, 514282

Abstract:

Disclosed herein are oral dosage forms of hydromorphone that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.

US Patent:

20080069871, Mar 20, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781008

Inventors:

Jason Vaughn - Round Rock TX, US
Michael Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 47/30
A61K 47/38
A61K 9/14
A61K 9/52
A61P 25/04

US Classification:

424456000, 424484000, 424487000, 514772600, 514781000

Abstract:

Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.

US Patent:

20080075768, Mar 27, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781044

Inventors:

Jason Vaughn - Round Rock TX, US
Michael Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 9/48
A61K 47/12
A61K 47/38
A61P 25/36
A61K 9/00

US Classification:

424456000, 424484000, 514781000, 514784000

Abstract:

Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid antagonists that are sequestered from the opioid therapeutic agent such that the opioid antagonist has no substantial effect on the activity of the opioid therapeutic agent when the dosage form is taken orally as prescribed, but the opioid antagonist is released in an amount that reduces the effectiveness of the opioid therapeutic agent contained in the dosage form when the dosage form is crushed.

US Patent:

20080075770, Mar 27, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781032

Inventors:

Jason Vaughn - Round Rock TX, US
Michael Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 9/56
A61K 31/34
A61P 25/04

US Classification:

424463000, 514468000

Abstract:

Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.

US Patent:

20080075771, Mar 27, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781050

Inventors:

Jason Vaughn - Round Rock TX, US
Michael Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 31/34
A61K 9/56
A61P 25/04

US Classification:

424463000, 514468000

Abstract:

Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid antagonists that are sequestered from the opioid therapeutic agent such that the opioid antagonist has no substantial effect on the activity of the opioid therapeutic agent when the dosage form is taken orally as prescribed, but the opioid antagonist is released in an amount that reduces the effectiveness of the opioid therapeutic agent contained in the dosage form when the dosage form is crushed.

US Patent:

20100047345, Feb 25, 2010

Filed:

Nov 4, 2009

Appl. No.:

12/612511

Inventors:

Michael M. Crowley - Austin TX, US
Feng Zhang - Austin TX, US
John Koleng - Austin TX, US
Justin Keen - Round Rock TX, US
Jason Vaughn - Round Rock TX, US
Justin Hughey - Austin TX, US

International Classification:

A61K 9/22
A61K 31/485

US Classification:

424468, 514282

Abstract:

Disclosed herein are oral dosage forms of hydromorphone that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.

US Patent:

20200167481, May 28, 2020

Filed:

Jan 30, 2020

Appl. No.:

16/777505

Inventors:

- Charlotte NC, US
Robert James Gray - Southlake TX, US
Cory David Brunner - Stanley NC, US
Jason Dean Vaughn - Jacksonville FL, US
Ryan Joseph Argomaniz - Sachse TX, US

Assignee:

BANK OF AMERICA CORPORATION - Charlotte NC

International Classification:

G06F 21/57
H04L 29/06

Abstract:

A system for generating entity-specific security-related inquiries and determining a frequency for invoking the inquiries based on integration of external security-related data and internal security related data. Specifically, a security threat level is determined for an entity and the components which comprise the security threat are identified. The components signify areas of focus for generating the entity-specific security-related inquiries. In further embodiments of the invention analytics are implemented to logically analyze the external security-related data and internal security related data and the results of which further refine the generation of the entity-specific security-related inquiries and/or determination of the frequency for invoking the inquiries.

US Patent:

20190163914, May 30, 2019

Filed:

Nov 30, 2017

Appl. No.:

15/827034

Inventors:

- Charlotte CA, US
Robert James Gray - Southlake TX, US
Cory David Brunner - Stanley NC, US
Jason Dean Vaughn - Jacksonville FL, US
Ryan Joseph Argomaniz - Sachse TX, US

International Classification:

G06F 21/57
H04L 29/06

Abstract:

A system for generating entity-specific security-related inquiries and determining a frequency for invoking the inquiries based on integration of external security-related data and internal security related data. Specifically, a security threat level is determined for an entity and the components which comprise the security threat are identified. The components signify areas of focus for generating the entity-specific security-related inquiries. In further embodiments of the invention analytics are implemented to logically analyze the external security-related data and internal security related data and the results of which further refine the generation of the entity-specific security-related inquiries and/or determination of the frequency for invoking the inquiries.